Qiuhong Tian
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
Journal: Nature communications
Published: April 21, 2025
Machine learning-based prognostic modeling and surgical value analysis of de novo metastatic invasive ductal carcinoma of the breast.
Journal: Updates in surgery
Published: October 17, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
Journal: Lancet (London, England)
Published: August 28, 2024
Derlin-1 exhibits oncogenic activities and indicates an unfavorable prognosis in breast cancer.
Journal: Cell biology international
Published: August 14, 2019
Effect of antitumor treatments on triple-negative breast cancer patients: A PRISMA-compliant network meta-analysis of randomized controlled trials.
Journal: Medicine
Published: November 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026